MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 23561-23570 Newer>
The Motley Fool
May 29, 2007
S.J. Caplan
Scouting the Latest IPOs An investor's roundup of new-issue hits, misses, and no-shows: Greenlight Capital Re... Sirtris Pharmaceuticals... Clean Energy Fuels Corp... etc. mark for My Articles 338 similar articles
The Motley Fool
May 29, 2007
Rick Aristotle Munarriz
Xinhua Fights for R-E-S-P-E-C-T The scandal-tagged Chinese media IPO wants some respect. mark for My Articles 46 similar articles
The Motley Fool
May 29, 2007
Rich Smith
Foolish Forecast: QinetiQ Charged Up The British cutting-edge technology company is set to release its quarterly earnings report. Investors, here is what you can expect to see. mark for My Articles 45 similar articles
The Motley Fool
May 29, 2007
Brian Lawler
Nektar Squeezes Itself Nektar Therapeutics cuts costs after a slower rollout of its lead compound. Investors, take note. mark for My Articles 34 similar articles
The Motley Fool
May 29, 2007
Tom Taulli
Aruba Networks Reaches Escape Orbit The company's wireless security technologies are flying off the shelves. Aruba's valuation is far from cheap, but investors are willing to pay a fat premium for its growth. mark for My Articles 63 similar articles
The Motley Fool
May 29, 2007
Rich Smith
Foolish Forecast: Ciena Still Black The networking specialist is set to report its fiscal second-quarter 2007. Investors, here is what you can expect to see. mark for My Articles 170 similar articles
The Motley Fool
May 29, 2007
Brian Lawler
The One Development-Stage Drug Stock to Own Now With such a low level of Remoxy sales baked into its share price, and minimal clinical trial risk, investors who consider Pain Therapeutics around today's share price won't be hurting in the long run, if you assume there will be a viable market for abuse-resistant opioids. mark for My Articles 327 similar articles
The Motley Fool
May 29, 2007
Brian Lawler
Amgen Is Vexed The European Union medical authority says no to Amgen's cancer compound. Investors, take note. mark for My Articles 178 similar articles
The Motley Fool
May 29, 2007
Selena Maranjian
The Petrochemical Plant Strategy Some companies are dealing with rising oil costs in unique ways. Enterprising investors intrigued by the Dow-Saudi Aramco deal might want to keep up with this story, as it looks like both parties will be spinning off part of this joint venture via an IPO on the Saudi exchange. mark for My Articles 364 similar articles
The Motley Fool
May 29, 2007
Sham Gad
FreightCar America Still on Track? Will a temporary decline in demand send this railroad freight car manufacturer off the rails? Investors, take note. mark for My Articles 95 similar articles
<Older 23561-23570 Newer>    Return to current articles.